Microdose Psychedelic Insights, in partnership with The Conscious Fund, is pleased to announce the next edition of Psychedelic Capital: The Gold Standard for Psychedelic Investing taking place on Thursday 29th October, 2020 at 1PM EST.
More on YorkPedia:
- Microdose Presents Psychedelic Capital – A Virtual Investment Conference Highlighting Prominent Industry Players
- Virtual Visa Card with Bitcoin Made Simple – Even Your Kids Can Do It
- Jamie Brown, MD, a Cardiothoracic Surgeon with UM Prince George’s Hospital Center – the University of Maryland Medical C
- Noelle Dunn, DMD, a Dentist with DUNN Dental Group
- Robert J. Gaines, MD, FACOS, an Orthopaedic Surgeon with Lubbock Diagnostic Clinic
(YorkPedia Editorial):- Toronto, Oct 30, 2020 (Issuewire.com) – Microdose Psychedelic Insights, in partnership with The Conscious Fund, is pleased to announce the next edition of Psychedelic Capital: The Gold Standard for Psychedelic Investing taking place on Thursday 29th October 2020 at 1 PM EST.
You may find free tickets, compliments of our sponsors, by clicking this link.
Today’s event has another all-star list of dignified speakers, including Mitchell Osak, CEO, Quanta Consulting, Partner; Jayashree Mitra, Zuber Lawler, Partner; Cody Shandraw, Ambria, Director of Business Development; Jessica Cadoch, Maya PBC, Research Manager; Kimberly Adams, LYT Consulting, Owner; Richard Skaife, The Conscious Fund, Co-Founding Partner; Pyton Nyquvest, Numinus, Chief Executive Officer; Henri Sant-Cassia, The Conscious Fund, Co-Founding Partner; Carlos Alvear MD, Yolitia Botanicals, Dr. Evan Wood, Chief Medical Officer at Numinus; Garyn Angel, Founder, Magical Brands; Michael Astone, Director, Mergers & Acquisitions, BDO Capital Advisors, LLC, Michael Franks, Managing Partner Noetic Psychedelic Fund; Dr. Jeremy Weate, Universal Ibogaine Inc.
Psychedelic Capital provides investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe.
This online event programming is dedicated to providing investment grade information for the emerging psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Previous events have featured engaging presentations by influential firms in the burgeoning field of psychedelic medicine.
Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space. As the psychedelic renaissance continues its remarkable progress, the need for deeper insights into the investment landscape is more important than ever before.
This monthly virtual conference is aimed at providing quality information about psychedelics from industry experts and thought leaders. To register for your free tickets please click here.
Can’t make the live show? No worries. If you grab a ticket, you’ll have access to the recordings which will be available post-event.
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.